Entering text into the input field will update the search result below

Immunomedics EPS in-line, beats on revenue

May 06, 2015 4:05 PM ETImmunomedics, Inc. (IMMU) StockBy: Mohit Manghnani, SA News Editor
  • Immunomedics (NASDAQ:IMMU): FQ3 EPS of -$0.13 in-line.
  • Revenue of $1.2M (+4.3% Y/Y) beats by $0.13M.
  • Press Release

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
IMMU--
Immunomedics, Inc.